These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1561237)

  • 1. Porphyrin photosensitization of multi-drug resistant cell types.
    Kessel D; Erickson C
    Photochem Photobiol; 1992 Mar; 55(3):397-9. PubMed ID: 1561237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.
    Kessel D; Woodburn K
    Br J Cancer; 1995 Feb; 71(2):306-10. PubMed ID: 7841045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S; Patel K; Singh H; Gollapudi S
    Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of multidrug resistance by fluorescent dyes.
    Kessel D; Beck WT; Kukuruga D; Schulz V
    Cancer Res; 1991 Sep; 51(17):4665-70. PubMed ID: 1873811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
    Elstad CA; Thrall BD; Raha G; Meadows GG
    Nutr Cancer; 1996; 25(1):47-60. PubMed ID: 8837861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumvention of adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells.
    Parekh HK; Mansuri-Torshizi H; Srivastava TS; Chitnis MP
    Cancer Lett; 1992 Jan; 61(2):147-56. PubMed ID: 1730138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport and binding of mesoporphyrin IX by leukemia L1210 cells.
    Kessel D; Kohn KI
    Cancer Res; 1980 Feb; 40(2):303-7. PubMed ID: 7356513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
    Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK; Chitnis MP; Embrey WM; Gregory EB
    Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of subcellular localization in initiation of apoptosis by photodynamic therapy.
    Kessel D; Luo Y; Deng Y; Chang CK
    Photochem Photobiol; 1997 Mar; 65(3):422-6. PubMed ID: 9077123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
    Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sites of photodamage in vivo and in vitro by a cationic porphyrin.
    Kessel D; Woodburn K; Henderson BW; Chang CK
    Photochem Photobiol; 1995 Nov; 62(5):875-81. PubMed ID: 8570726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87.
    Miyamoto K; Wakusawa S; Nakamura S; Koshiura R; Otsuka K; Naito K; Hagiwara M; Hidaka H
    Cancer Lett; 1990 May; 51(1):37-42. PubMed ID: 2337896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring multidrug resistance using rhodamine 123.
    Kessel D
    Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
    J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic activity of mitoxantrone and its biological interactions in parental and multidrug resistant subline of P388 murine leukemia cells.
    Chavan S; Parekh H; Chitnis M
    Neoplasma; 1992; 39(1):49-57. PubMed ID: 1528304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed exposure of SDZ PSC 833 to multidrug resistant P388/ADR and MCF7/ADR cells in the absence of anticancer drugs can fully restore sensitivity to doxorubicin.
    Krishna R; de Jong G; Mayer LD
    Anticancer Res; 1997; 17(5A):3329-34. PubMed ID: 9413167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.